Search Results
Jan 28, 2026, 04:35 ET Yutong Bus Reports Continued Sales Growth in 2025, Advancing Sustainable Public Transportation Worldwide
control systems. Meanwhile, Yutong's product innovation has also gained industry recognition. At the 2025 Busworld Europe in Belgium, the Yutong T14E and U15 models were awarded the "Grand Award Coach " and the "Grand Award Bus" respectively.Product performance and operational reliability were validated
More news about: Yutong Bus
Jan 28, 2026, 04:01 ET Phemex ra mắt Chương trình Tuyển chọn nhà giao dịch ưu tú, tập trung vào Copy Trading chuyên nghiệp
multimedia:https://www.prnewswire.com/vn/news-releases/u0070u0068u0065u006Du0065u0078u002Du0072u0061u002Du006Du1EAFu0074u002Du0063u0068u01B0u01A1u006Eu0067u002Du0074u0072u0069u006Eu0068u002Du0074-302672402.htmlSOURCE
More news about: Phemex
Jan 28, 2026, 03:40 ET Yutong Bus Reports Continued Sales Growth in 2025, Advancing Sustainable Public Transportation Worldwide
control systems. Meanwhile, Yutong's product innovation has also gained industry recognition. At the 2025 Busworld Europe in Belgium, the Yutong T14E and U15 models were awarded the "Grand Award Coach " and the "Grand Award Bus" respectively.Product performance and operational reliability were validated
More news about: Yutong Bus
Jan 28, 2026, 03:25 ET MBZUAI, UAE의 완전 주권형 차세대 추론 시스템 K2 Think V2 출시
content:https://www.prnewswire.com/kr/news-releases/u006Du0062u007Au0075u0061u0069u002Cu002Du0075u0061u0065uC758u002DuC644uC804u002DuC8FCuAD8CuD615u002DuCC28uC138uB300u002DuCD94uB860u002DuC2DC-302672373.htmlSOURCE
More news about: Mohamed bin Zayed University of Artificial Intelligence (MBZUAI)
Jan 28, 2026, 03:25 ET 두바이, 중동•아프리카•남아시아 최대 규모의 수요 주도형 금융 중심지 확장 발표… 총 연면적 1770만 제곱피트
content:https://www.prnewswire.com/kr/news-releases/uB450uBC14uC774u002Cu002DuC911uB3D9u2022uC544uD504uB9ACuCE74u2022uB0A8uC544uC2DCuC544u002DuCD5CuB300u002DuADDCuBAA8uC758u002DuC218uC694u002D-302672374.htmlSOURCE
More news about: Dubai International Financial Centre (DIFC)
Jan 28, 2026, 03:11 ET Společnost Skyhawk Therapeutics oznamuje průběžné výsledky za devět měsíců u pacientů z 1. fáze klinického hodnocení přípravku SKY-0515 pro léčbu Huntingtonovy choroby
srovnání s očekávaným zhoršením cUHDRS po devíti měsících u symptomatických pacientů o -0,73 bodu na základě vážení skóre náchylnosti s použitím Enroll-HD a TRACK-HD.„Údaje o bezpečnosti a účinnosti ze studie SKY-0515 fáze 1 části C u pacientů jsou velmi povzbudivé a ukazují odchylku cUHDRS od
More news about: Skyhawk Therapeutics
Jan 28, 2026, 02:18 ET Xinhua Silk Road: 중국 동부에서 글로벌 해운•원자재 시장 동향을 가늠할 산업 지수 공개
content:https://www.prnewswire.com/kr/news-releases/u0078u0069u006Eu0068u0075u0061u002Du0073u0069u006Cu006Bu002Du0072u006Fu0061u0064u003Au002DuC911uAD6Du002DuB3D9uBD80uC5D0uC11Cu002DuAE00uB85C-302672312.htmlSOURCE
More news about: Xinhua Silk Road
Jan 28, 2026, 01:41 ET Phemex introduceert Elite Trader Recruitment Program gericht op professioneel copytrading
betrouwbare tools, inclusieve toegang en ontwikkelende kansen voor handelaren op elk niveau om te groeien en te slagen.Voor meer informatie kunt u terecht op: https://phemex.com/
More news about: Phemex
Jan 28, 2026, 01:15 ET 제5회 미래 광물 포럼, 참가자 2만 1500명 기록 및 미화 266억 달러 규모 계약 체결하며 성료
content:https://www.prnewswire.com/kr/news-releases/uC81Cu0035uD68Cu002DuBBF8uB798u002DuAD11uBB3Cu002DuD3ECuB7FCu002Cu002DuCC38uAC00uC790u002Du0032uB9CCu002Du0031u0035u0030u0030uBA85u002DuAE30-302672229.htmlSOURCE
More news about: The Future Minerals Forum
Jan 27, 2026, 23:53 ET Boehringer Ingelheim en Simcere werken samen aan een dubbeldoelgerichte antilichaambehandeling om tegemoet te komen aan onvervulde behoeften bij inflammatoire darmziekten
innovatie, heeft Simcere strategische samenwerkingspartnerschappen met veel innovatieve bedrijven en onderzoeksinstituten opgezet. Meer informatie vindt u op www.simcere.com.Over Boehringer IngelheimBoehringer Ingelheim is een
More news about: Simcere Pharmaceutical Group Limited
Jan 27, 2026, 22:10 ET Spoločnosť Skyhawk Therapeutics oznamuje predbežné výsledky u pacientov z fázy 1 klinického skúšania lieku SKY-0515 za deväť mesiacov liečby Huntingtonovej choroby
po deviatich mesiacoch cUHDRS u symptomatických pacientov o -0,73 bodu, na základe váženia skóre propensity pomocou platformy Enroll-HD a skúšania TRACK-HD.„Veľmi ma povzbudzujú tieto údaje o bezpečnosti a skorej účinnosti zo skúšania fázy 1 časti C lieku SKY-0515 u pacientov, ktoré ukazujú odchýlku
More news about: Skyhawk Therapeutics
Jan 27, 2026, 21:00 ET TẬP ĐOÀN SUNHOUSE VÀ ANCHANTO THIẾT LẬP QUAN HỆ ĐỐI TÁC CHIẾN LƯỢC: SỐ HÓA CHUỖI CUNG ỨNG ĐA QUỐC GIA THÚC ĐẨY TĂNG TRƯỞNG TMĐT 300%
content:https://www.prnewswire.com/vn/news-releases/u0074u1EADu0070u002Du0111u006Fu0061u006Eu002Du0073u0075u006Eu0068u006Fu0075u0073u0065u002Du0076u0061u002Du0061u006Eu0063u0068u0061u006Eu0074-302671328.htmlSOURCE
More news about: Anchanto
Jan 27, 2026, 15:49 ET DARZALEX FASPRO®-based quadruplet regimen approved in the U.S. for newly diagnosed patients with multiple myeloma who are transplant ineligible
https://www.jnj.com/media-center/press-releases/darzalex-faspro-daratumumab-and-hyaluronidase-fihj-based-quadruplet-regimen-approved-in-the-u-s-for-patients-with-newly-diagnosed-multiple-myeloma-who-are-transplant-eligible Accessed January 2026.
More news about: Johnson & Johnson
Jan 27, 2026, 15:31 ET Yili duy trì vị thế trong 500 thương hiệu giá trị nhất thế giới
multimedia:https://www.prnewswire.com/vn/news-releases/u0079u0069u006Cu0069u002Du0064u0075u0079u002Du0074u0072u0069u002Du0076u1ECBu002Du0074u0068u1EBFu002Du0074u0072u006Fu006Eu0067u002Du0035u0030-302671715.htmlSOURCE
More news about: Yili Group
Jan 27, 2026, 14:06 ET Analytic Partners reconocido como líder por múltiples empresas de investigación independientes
sus publicaciones de investigación y no aconseja a los usuarios de tecnología que seleccionen solo a los proveedores con las calificaciones más altas u otras designaciones. Las publicaciones de investigación de Gartner consisten en las opiniones de la organización de investigación y asesoría de Gartner
More news about: Analytic Partners
Jan 27, 2026, 14:01 ET La estimulación eléctrica faríngea: una herramienta importante para la recuperación post-ictus
de neuromodulación clínicamente validada que ayuda a restaurar la deglución segura y eficiente en pacientes afectados por un accidente cerebrovascular u otra lesión neurológica. En los Estados Unidos, Phagenyx está indicado para la disfagia grave posterior a un accidente cerebrovascular y en Europa tiene
More news about: Phagenesis
Jan 27, 2026, 13:30 ET An InventHelp 123Invent Inventor Develops Improved Road Grader for ATVs & UTVs (CTK-2222)
grade a roadway, level gravel, or fill potholes using an ATV or UTV," said an inventor, from Sioux Falls, S.D., "so I invented the FRONT END A T V OR U T V GRADER. My design offers an improved front-mounted alternative to traditional grader devices that can only be used in one direction."
More news about: InventHelp
Jan 27, 2026, 10:49 ET Xây dựng nền tảng cốt lõi cho sản xuất điện mặt trời thông minh: Khu Công nghiệp Điện mặt trời thông minh SKYWORTH đạt mốc cất nóc kết cấu chính
content:https://www.prnewswire.com/vn/news-releases/u0078u0061u0079u002Du0064u1EF1u006Eu0067u002Du006Eu1EC1u006Eu002Du0074u1EA3u006Eu0067u002Du0063u1ED1u0074u002Du006Cu006Fu0069u002Du0063u0068-302671412.htmlSOURCE
More news about: SKYWORTH PV
Jan 27, 2026, 10:22 ET Skyhawk Therapeutics Công Bố Kết Quả Nghiên Cứu Tạm Thời trên Bệnh Nhân sau 9 Tháng tiến hành Thử Nghiệm Lâm Sàng Giai Đoạn 1 thuốc SKY-0515 để Điều Trị bệnh Huntington
content:https://www.prnewswire.com/vn/news-releases/u0073u006Bu0079u0068u0061u0077u006Bu002Du0074u0068u0065u0072u0061u0070u0065u0075u0074u0069u0063u0073u002Du0063u006Fu006Eu0067u002Du0062u1ED1-302671380.htmlSOURCE
More news about: Skyhawk Therapeutics
Jan 27, 2026, 10:18 ET SPH Consulting Group Shares a Guide to Leading Higher Ed Mergers & Closures in Today's Challenging Environment
sector's most difficult challenges."Jeffrey SelingoAuthor of Dream School: Finding The College That's Right For You, co-host of Future U., special advisor to the president of Arizona State UniversityABOUT THE AUTHORSRicardo Azziz (VESTAVIA HILLS, AL) is the director
More news about: SPH Consulting Group
Jan 27, 2026, 09:40 ET Skyhawk Therapeutics ogłasza dziewięciomiesięczne wyniki pośrednie badań klinicznych fazy 1 nad lekiem SKY-0515 stosowanym w leczeniu choroby Huntingtona
miesiącach w skali cUHDRS u pacjentów z objawami wynoszącym -0,73 punktu, w oparciu o ważenie wykonane metodą odwrotności prawdopodobieństwa przy użyciu Enroll-HD i TRACK-HD.„Dane dotyczące bezpieczeństwa i wstępnej skuteczności uzyskane w badaniach fazy 1 część C nad lekiem SKY-0515 u pacjentów dają duże
More news about: Skyhawk Therapeutics
Jan 27, 2026, 09:00 ET New Study Identifies Hidden Scalp Inflammation That May Explain Why Androgenetic Pattern Hair Loss Treatments Stop Working
vary.Media Contact: Alice Lee, PR Coordinator, Dr. U Hair and Skin Clinic; Phone: +1-310-318-1500, Email: [email protected] Sanusi Umar, MD, is a board-certified dermatologist, founder of Dr. U Hair and Skin Clinic in Manhattan Beach, and a clinical
More news about: Dr. U Hair and Skin Clinic
Jan 27, 2026, 08:32 ET Chungnam National University Develops AI Model to Accelerate Defect-Based Material Design
simulations with rapid, reliable predictions, facilitating the systematic exploration of defect-rich regimes," says Prof. Na.The model employs a 3D U-Net architecture, a convolutional neural network widely used in scientific and medical image analysis, to capture both global orientational order and
More news about: Chungnam National University
Jan 27, 2026, 08:19 ET Univar Solutions y Ashland forjan una alianza exclusiva para éteres de celulosa
"puede", "deberá", "podría", "busca", "pretende", "planea", "estima", "anticipa" u otros términos comparables. Todas las declaraciones prospectivas realizadas en este comunicado están sujetas a este texto de advertencia.
More news about: Univar Solutions LLC
Jan 27, 2026, 08:00 ET 스카이호크 테라퓨틱스, 헌팅턴병 치료제 SKY-0515 제1상 임상시험 환자 대상 9개월 중간 결과 발표
content:https://www.prnewswire.com/kr/news-releases/uC2A4uCE74uC774uD638uD06Cu002DuD14CuB77CuD4E8uD2F1uC2A4u002Cu002DuD5CCuD305uD134uBCD1u002DuCE58uB8CCuC81Cu002Du0073u006Bu0079u002Du0030u0035-302671087.htmlSOURCE
More news about: Skyhawk Therapeutics